Our work

Three pillars, one coordinated voice

A small number of high-impact workstreams to establish credibility, demonstrate progress and build long-term institutional relationships.

01

Regulatory

Engage with regulators to drive an agenda and strengthen enforcement of standards.

Responsible access: support appropriate prescribing by GPs and specialists, including digital pathways
Integrity: a clear distinction between medical and recreational products under robust Good Manufacturing Practice (GMP) standards
Accountability: responsible communications and stronger enforcement against recreational advertising
Collaboration: work with the British Standards Institution (BSI) and neighbouring trade bodies to raise standards

02

Institutional voice

Build the industry's voice through public affairs, communications and stakeholder engagement.

Align responsible operators around shared priorities
Lead evidence-based policy and consultation responses
Engage government, regulators, Parliament and the National Health Service (NHS)
Build public trust through a unified industry voice

03

Science & evidence

Build the evidence that patients, prescribers and regulators need, working with clinics, clinicians and researchers.

Develop a shared data collection tool with members and partner clinics
Collect real-world data on quality of life and treatment efficacy
Measure safety, adverse effects and health economic outcomes
Work with clinicians and researchers, including the Medical Cannabis Clinicians Society (MCCS)

Explore our evidence work

Finding common ground

Open questions the industry must align on, from quickest to longest-term.

Step 1
Advertising standards
An advertising code of conduct, with a kitemark and exclusion.
Step 2
The future framework for medicines
Explore pathways for cannabis-based products for medicinal use (CBPMs), informed by the upcoming Advisory Council on the Misuse of Drugs (ACMD) review.

Help shape it from day one

Book a 30-minute call to see the full plan.

Register your interest →